573 related articles for article (PubMed ID: 25979217)
1. Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study.
Boudaoud N; Binet A; Line A; Chaouadi D; Jolly C; Fiquet CF; Ripert T; Merol ML
J Pediatr Urol; 2015 Jun; 11(3):138.e1-10. PubMed ID: 25979217
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS
J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
[TBL] [Abstract][Full Text] [Related]
3. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
[TBL] [Abstract][Full Text] [Related]
4. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
[TBL] [Abstract][Full Text] [Related]
5. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.
Amarenco G; Ismael SS; Even-Schneider A; Raibaut P; Demaille-Wlodyka S; Parratte B; Kerdraon J
J Urol; 2003 Jun; 169(6):2210-5. PubMed ID: 12771752
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial.
Finazzi-Agrò E; Petta F; Sciobica F; Pasqualetti P; Musco S; Bove P
J Urol; 2010 Nov; 184(5):2001-6. PubMed ID: 20850833
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA
J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
[TBL] [Abstract][Full Text] [Related]
9. Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: A prospective randomized controlled study.
Marzouk MH; Darwish MH; El-Tamawy MS; Morsy S; Abbas RL; Ali AS
Mult Scler Relat Disord; 2022 Dec; 68():104252. PubMed ID: 36274285
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.
Peters KM; Carrico DJ; Perez-Marrero RA; Khan AU; Wooldridge LS; Davis GL; Macdiarmid SA
J Urol; 2010 Apr; 183(4):1438-43. PubMed ID: 20171677
[TBL] [Abstract][Full Text] [Related]
11. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
Martin-Garcia M; Crampton J
Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
[TBL] [Abstract][Full Text] [Related]
12. [Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson's syndromes].
Ohannessian A; Kaboré FA; Agostini A; Lenne Aurier K; Witjas T; Azulay JP; Karsenty G
Prog Urol; 2013 Sep; 23(11):936-9. PubMed ID: 24010924
[TBL] [Abstract][Full Text] [Related]
13. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
Malone-Lee JG; Al-Buheissi S
BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
[TBL] [Abstract][Full Text] [Related]
14. [Tibial nerve transcutaneous stimulation for refractory idiopathic overactive bladder in children and adolescents].
Bouali O; Even L; Mouttalib S; Moscovici J; Galinier P; Game X
Prog Urol; 2015 Sep; 25(11):665-72. PubMed ID: 26022237
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
Lashin AM; Eltabey NA; Wadie BS
Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence.
Hagstroem S; Mahler B; Madsen B; Djurhuus JC; Rittig S
J Urol; 2009 Oct; 182(4 Suppl):2072-8. PubMed ID: 19695629
[TBL] [Abstract][Full Text] [Related]
17. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease.
Kabay SC; Kabay S; Yucel M; Ozden H
Neurourol Urodyn; 2009; 28(1):62-7. PubMed ID: 18837432
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
Rai BP; Cody JD; Alhasso A; Stewart L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
[TBL] [Abstract][Full Text] [Related]
19. No immediate effect on urodynamic parameters during transcutaneous electrical nerve stimulation (TENS) in children with overactive bladder and daytime incontinence-A randomized, double-blind, placebo-controlled study.
Borch L; Rittig S; Kamperis K; Mahler B; Djurhuus JC; Hagstroem S
Neurourol Urodyn; 2017 Sep; 36(7):1788-1795. PubMed ID: 27868230
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous tibial nerve stimulation in treatment of overactive bladder: when should retreatment be started?
Marchal C; Herrera B; Antuña F; Saez F; Perez J; Castillo E; Cantero J; Milla F; Machuca J; Redondo M; Galacho A
Urology; 2011 Nov; 78(5):1046-50. PubMed ID: 21908024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
